CN101022792A - 新化合物、包含该化合物的药物组合物及该化合物的应用方法 - Google Patents

新化合物、包含该化合物的药物组合物及该化合物的应用方法 Download PDF

Info

Publication number
CN101022792A
CN101022792A CNA2005800233119A CN200580023311A CN101022792A CN 101022792 A CN101022792 A CN 101022792A CN A2005800233119 A CNA2005800233119 A CN A2005800233119A CN 200580023311 A CN200580023311 A CN 200580023311A CN 101022792 A CN101022792 A CN 101022792A
Authority
CN
China
Prior art keywords
chemical compound
alkyl
aryl
pharmaceutical composition
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800233119A
Other languages
English (en)
Chinese (zh)
Inventor
J·M·斯图尔蒂万特
C·A·汤森
S·M·迈德加尔希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Fasgen LLC
Original Assignee
Johns Hopkins University
Fasgen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, Fasgen LLC filed Critical Johns Hopkins University
Publication of CN101022792A publication Critical patent/CN101022792A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
CNA2005800233119A 2004-05-26 2005-05-25 新化合物、包含该化合物的药物组合物及该化合物的应用方法 Pending CN101022792A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57463904P 2004-05-26 2004-05-26
US60/574,639 2004-05-26

Publications (1)

Publication Number Publication Date
CN101022792A true CN101022792A (zh) 2007-08-22

Family

ID=35463277

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800233119A Pending CN101022792A (zh) 2004-05-26 2005-05-25 新化合物、包含该化合物的药物组合物及该化合物的应用方法

Country Status (13)

Country Link
US (1) US20090005435A1 (cg-RX-API-DMAC7.html)
EP (1) EP1758577A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008500363A (cg-RX-API-DMAC7.html)
KR (1) KR20070095754A (cg-RX-API-DMAC7.html)
CN (1) CN101022792A (cg-RX-API-DMAC7.html)
AU (1) AU2005249437A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0510397A (cg-RX-API-DMAC7.html)
CA (1) CA2568639A1 (cg-RX-API-DMAC7.html)
IL (1) IL179530A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06013687A (cg-RX-API-DMAC7.html)
RU (1) RU2006146051A (cg-RX-API-DMAC7.html)
WO (1) WO2005117590A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700024B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014248A2 (en) * 2005-07-26 2007-02-01 Johns Hopkins University Method of reducing food intake
AU2007300627B2 (en) * 2006-09-22 2012-02-16 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
KR101640263B1 (ko) * 2007-10-05 2016-07-15 젠자임 코포레이션 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
WO2014039769A1 (en) * 2012-09-07 2014-03-13 Janssen Pharmaceutica Nv Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
CA2968288A1 (en) 2014-11-20 2016-05-26 Vib Vzw Means and methods for treatment of early-onset parkinson's disease
CN114980740A (zh) 2020-01-23 2022-08-30 巴斯夫欧洲公司 用于农业化学配制剂的新型添加剂
CN116507203B (zh) 2020-10-27 2026-08-07 巴斯夫欧洲公司 农药微乳剂组合物
CA3207197A1 (en) 2021-02-05 2022-08-11 Murat Mertoglu Liquid herbicidal compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
MXPA04007556A (es) * 2002-02-08 2005-12-05 Univ Johns Hopkins Med Estimulacion de cpt-1 como medio para reducir peso.
US7649012B2 (en) * 2002-07-09 2010-01-19 Fasgen, Inc. Compounds, pharmaceutical compositions containing same, and methods of use for same

Also Published As

Publication number Publication date
WO2005117590A3 (en) 2006-07-27
WO2005117590A2 (en) 2005-12-15
ZA200700024B (en) 2008-06-25
JP2008500363A (ja) 2008-01-10
AU2005249437A1 (en) 2005-12-15
RU2006146051A (ru) 2008-07-10
EP1758577A2 (en) 2007-03-07
BRPI0510397A (pt) 2007-11-13
US20090005435A1 (en) 2009-01-01
EP1758577A4 (en) 2010-05-05
CA2568639A1 (en) 2005-12-15
IL179530A0 (en) 2007-05-15
MXPA06013687A (es) 2007-10-18
KR20070095754A (ko) 2007-10-01

Similar Documents

Publication Publication Date Title
He et al. Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
US5614551A (en) Inhibitors of fatty acid synthesis as antimicrobial agents
US7649012B2 (en) Compounds, pharmaceutical compositions containing same, and methods of use for same
KR20050072670A (ko) 신규 화합물, 이를 함유하는 약제학적 조성물 및 이의사용방법
JP2006512290A (ja) 自己誘導物質類似物質、自己誘導物質アゴニストおよびアンタゴニストのコンビナトリアル・ライブラリー、ならびにその使用方法
CA2617659C (en) Use of hydroxybenzoic acid esters and analogues for the manufacture of a medicament for the prevention and treatment of virus infection
CN109562118A (zh) 非口服给药用医药组合物
Sundaresan et al. Synthesis, characterization and biological evaluations of some novel cyanoacetyl hydrazone derivatives
JP2008500363A (ja) 新規化合物、該化合物を含む医薬組成物、および該化合物の使用方法
CN114890882B (zh) 柏木醇衍生物、其制备方法及其应用
CN102579427A (zh) 合成的内酯制剂及其使用方法
CN116832036A (zh) 一种Erysotrine化合物及其衍生物的应用
HK1112837A (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HK1086485B (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
US20100029761A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
Abbasi et al. Synthesis, Antibacterial and Lipoxygenase Inhibition Studies of N-(Alkyl/aralkyl)-N-(2, 3-dihydro-1, 4-benzodioxin-6-yl)-4-methylbenzenesulfonamides
WO2007014249A2 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
RU2073512C1 (ru) Способ лечения аспергиллеза у кроликов
CN120771147A (zh) 一种吡唑化合物及其衍生物的应用
CN101397341A (zh) 一种来源于纳豆的脂肪酶抑制剂及其制备方法和用途
CN105777505A (zh) 一种新型氟代ptp1b抑制剂及其合成和应用
JPH0327316A (ja) 高脂血症治療剤
HK1057499B (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
CN104610224A (zh) 一类卤代苯基噻吩酰胺类双靶点抑制剂及其用途
CN104610223A (zh) 一类噻吩酰胺甲苯类sglt2/sglt1双靶点抑制剂及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1112837

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070822

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1112837

Country of ref document: HK